UNITY-NHL open at Hollywood Private HospitalChan Cheah
The UNITY-NHL study is now open at Hollywood Private Hospital. This phase IIB study is exploring the phosphatidylinositol-3-kinase delta inhibitor, umbralisib, either alone or in combination with an antibody against CD20 ublituximab in patients with previously treated follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma. For more information visit the trial home page or speak to your Haematologist.
We will be opening the study at Sir Charles Gairdner Hospital in September to October 2018 for public patients.